Navigation Links
Delcath Systems Receives Preliminary Notification of Inclusion in Russell 3000(R) Index
Date:6/15/2009

ing the patient's bloodstream. The Company is currently enrolling patients in Phase III and Phase II clinical studies for the treatment of liver cancers using high doses of melphalan. The Company's intellectual property portfolio consists of twenty-seven patents on a worldwide basis including the U.S., Europe, Asia and Canada. For more information, please visit the Company's website at www.delcath.com.


'/>"/>
SOURCE Delcath Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Delcath Enters Agreement to Sell 869,565 Units
2. Delcath Systems Granted Third Orphan Drug Designation
3. Eric D. Whitman, MD to Present on the Delcath PHP System(TM) at the 7th World Congress on Melanoma
4. Enrollment in Delcaths Pivotal Phase III Metastatic Melanoma Clinical Trial Reaches Halfway Point
5. Delcath Adds Senior Pharmaceutical Professional to Its Board of Directors
6. Jonathan Lewis, M.D., Ph.D. Steps Down From Delcath Systems Board of Directors
7. Delcath Adds University of Pittsburgh Medical Center to Phase III Trial
8. Nanopoint Applies CE Mark to Its cellTRAY(R) Imaging and Microfluidics Systems
9. Penguin Computing Forms OEM Agreement with Applied Biosystems for Scyld ClusterWare
10. SANYO Donates Air Purification Systems Effective Against Flu Viruses to New York Airports and Schools
11. OmniComm Systems Appoints EDC Veteran Dr. Wolfgang Summa to Executive Vice President, Europe & Asia/Pacific

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2009)..., NEW YORK, Nov. 18 Reportlinker...s available in its catalogue. ,, Biotechnolog... http://www.reportlinker.com/p0164375/Biotechnolog...source=prnewswire&utm_medium=pr&utm_campai...gy are complex chemical compounds used in a range ...
(Date:11/18/2009)... Promega Corporation and SwitchGear G... DNA-protein interactions. , ...Promega Corporation and SwitchGear Genomics announ...nteractions. Results of a study using the HaloCHIP... demonstrate the ability to correlate DNA binding ...
(Date:11/18/2009)...VT-111 significantly reduces key cardiac enzymes a... presented at American Heart Association 2009 Scie...wire/ - Viron Therapeutics Inc., a biotechnology c...ting protein therapeutics derived from pathogens, ...rial evaluating VT-111 (Serp-1), an anti-inflammat...
(Date:11/18/2009)..., BALTIMORE, Nov. 18 Ch...CSBR), an oncology drug development company with a...ting the development and enhancing the value of on...ng agreement with Yale University and Southern Res...or cancer treatment. Scientists from Yale and Sou...
Breaking Biology Technology:Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 3Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 5Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 6Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 7Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 8Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional Activity 2Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 2Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 3Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 4Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Oncology 2Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Oncology 3Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Oncology 4
...t microRNA-based Diagnostic Tests are Expected to ...Nanogen,s MGB Probe Technology, Rosetta Genomics ...igned, Real-Time PCR Diagnostic Assays That Allo...on of microRNA in Tissues and Body Fluids, REHOVO...1, Rosetta Genomics, Ltd. (NASDQ: ROSG) announced,...
...YORK, Dec. 10 /Xinhua-PRNewswire-FirstCall/ -- Chi...rd: CYIG; hereinafter the,"Company") announced tod...o. Ltd. ("Shandong YCT"), the Company,s wholly-own...a, has been awarded the honor of China,s "Top 100,...euticals sector. The,award was conferred by the Sm...
...ON, Dec. 10 Oxford Finance Corporation and GE,Hea...ounds Sterling 7.5,million senior secured loan to ... the largest venture loans provided to a biotechno...d in Cambridge, England, is one of the largest,pri...ting on the discovery,and development of small mol...
Other Biology Technology:Rosetta Genomics Selects PCR as Platform for its microRNA-based Diagnostics to be Launched in 2008, Licensed Nanogen's MGB Probe Technology 2Rosetta Genomics Selects PCR as Platform for its microRNA-based Diagnostics to be Launched in 2008, Licensed Nanogen's MGB Probe Technology 3Rosetta Genomics Selects PCR as Platform for its microRNA-based Diagnostics to be Launched in 2008, Licensed Nanogen's MGB Probe Technology 4CYIG Awarded China's "Top 100 Enterprises" in New Pharmaceuticals, Selected as National "'Torch Plan' Key High-Tech Enterprise" 2Oxford Finance Corporation and GE Healthcare Financial Services Reaffirm Commitment to Biotech Sector in Europe 2
(Date:11/22/2009)...rch Centre, a partnership of the University of Bri...astal Health Research Institute, have uncovered ne...ells die following a stroke, as well as a possible...tudy were recently published online in Nature Med...ontinue to die even after blood flow has been rest...
(Date:11/20/2009)...read studies about the health benefits of having a...ular level, where amino acids known as cysteines a... when paired up with other cysteines. , Now, res... colleagues in Belgium, have discovered a new anti... research appears in the Nov. 20 issue of the jour...
(Date:11/20/2009)...009) Scientists from the Marine Biogeochemistry a...search Laboratory (NRL) organized and led a team o...c expedition to initiate methane hydrate explorati...ariation of sediment contribution to Arctic climat...r Polar Sea as a research platform, three cross-sh...
Breaking Biology News(10 mins):New understanding about mechanism for cell death after stroke leads to possible therapy 2Saving the single cysteine: New antioxidant system found 2International expedition investigates climate change, alternative fuels in Arctic 2H D Smith Promotes Leadership to Fill Two Senior Roles 51210 1H D Smith Promotes Leadership to Fill Two Senior Roles 51210 2ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 1ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 2ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 3ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 4ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 5Study identifies potential fix for damaged knees 51203 1Study identifies potential fix for damaged knees 51203 2Study identifies potential fix for damaged knees 51203 3
... heart cells in culture to mimic the properties of...t into the mechanisms that spawn irregular heart r...evealed that while electric shocks such as those d...t waves, in some cases they cause them to accelera...opkins University team, led by Nenad Bursac of Duk...
...spectrometry for decades to determine the chemical...d to identify viruses, and never in complex enviro...ns Bloomberg School of Public Health recently demo...potential to be applied for this purpose. Using a ...ed, purified and concentrated a norovirus surrogat...
..., formerly a Senior Research Associate at the Stow...urquié, Ph.D., Stowers Institute Investigator and ...titute, have demonstrated that the long-studied fa...essed in a cyclic fashion during the formation of ...bryo. , The findings, which were published in the...
Other Biology News:Engineered heart tissue offers insights into irregular heartbeats, defibrillator failure 2Engineered heart tissue offers insights into irregular heartbeats, defibrillator failure 3Researchers use mass spectrometry to detect norovirus particles 2Stowers scientists demonstrate mechanism of vertebral formation 2
Mouse Anti-Human PPP2R2C Monoclonal Antibody, Unconjugated, Clone 6D1 from Novus Biologicals
96-well 0.2 ml PCR Plate Caps, 300 from Bio-Rad
PROTEIN G PLUS AGAROSE from Pierce Biotechnology, Inc.
Mouse Anti-Human ALS2CR8 Polyclonal Antibody, Unconjugated from Novus Biologicals
Biology Products: